VJHemOnc is committed to improving our service to you

EHA 2019 | All things ibrutinib and CLL

VJHemOnc is committed to improving our service to you

Lydia Scarfò

Lydia Scarfò, MD, Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, Milan, describes when and how to use ibrutinib for the treatment of chronic lymphocytic leukemia (CLL) at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands. Dr Scarfo goes on to give her thoughts on the long-term, real-world data available for ibrutinib.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter